Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	262.52	257.84	273.74	99.7	142.14	133.54
Short-Term Investments	110.9	153.76	-	-	-	-
Cash & Short-Term Investments	373.42	411.59	273.74	99.7	142.14	133.54
Cash Growth	75.78%	50.36%	174.55%	-29.86%	6.44%	66.73%
Other Current Assets	7.14	7.73	7.88	4.17	3.91	3.68
Total Current Assets	380.56	419.32	281.62	103.87	146.06	137.22
Other Intangible Assets	-	-	-	0.53	3.69	6.87
Goodwill	19.92	19.92	19.92	19.92	19.92	19.92
Other Long-Term Assets	0.81	0.86	0.61	0.22	0.33	-
Total Assets	401.29	440.1	302.15	124.54	169.99	164
Accounts Payable	7.13	5.35	2.01	4.14	2.11	4.18
Accrued Expenses	24.51	20.45	12.83	11.63	5.88	6.23
Other Current Liabilities	49.47	40.91	24.01	16.48	9.9	-
Total Current Liabilities	81.11	66.7	38.85	32.25	17.89	10.41
Long-Term Debt	40.77	40.58	21.85	14.13	-	-
Other Long-Term Liabilities	0.56	0.5	-	0.03	1.18	1.93
Total Long-Term Liabilities	41.33	41.08	21.85	14.16	1.18	1.93
Total Liabilities	122.44	107.77	60.7	46.41	19.08	12.34
Additional Paid-in Capital	937.8	913.91	639.51	367.99	344.76	288.29
Accumulated Other Comprehensive Income	0.82	1.09	0.82	0.34	0.63	1.05
Retained Earnings	-659.77	-582.67	-398.88	-290.2	-194.47	-137.67
Shareholders' Equity	278.85	332.33	241.45	78.13	150.92	151.66
Total Liabilities & Equity	401.29	440.1	302.15	124.54	169.99	164
Total Debt	40.77	40.58	21.85	14.13	0	0
Net Cash (Debt)	332.65	371.01	251.89	85.58	142.14	133.54
Net Cash Growth	-10.34%	47.29%	194.35%	-39.80%	6.44%	66.73%
Net Cash Per Share	3.49	4.15	3.58	2.19	4.61	4.88
Book Value	278.85	332.33	241.45	78.13	150.92	151.66
Book Value Per Share	2.93	3.72	3.43	2.00	4.89	5.54
Tangible Book Value	258.93	312.41	221.53	57.69	127.31	124.88
Tangible Book Value Per Share	2.72	3.50	3.14	1.47	4.13	4.56

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.